Log In
Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Forgot your password?
Log In
Don't have an account? Sign Up Here
Join Us
Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
I agree to TheMaven's
Terms
and
Policy
Sign Up
Already have an account? Login here
JIM CRAMER
INVESTING
PERSONAL FINANCE
RETIREMENT
TECHNOLOGY
MARKETS
HOW-TO
VIDEO
FINANCIAL ADVISOR CENTER
Search
Trade with Jim Cramer 14 Days Free
Join the Action Alerts PLUS Community today!
SUBSCRIBE NOW
LATEST NEWS
STOCKS
What Adam Feuerstein Got Right and Wrong About Biotech Stocks in 2016
By Adam Feuerstein
Dec 22, 2016 11:20 AM EST
PRESS RELEASES
CTI BioPharma To Present At The JMP Securities Hematology Summit On Tuesday, Dec. 15
By PR Newswire
Dec 8, 2020 7:00 AM EST
PRESS RELEASES
CTI BioPharma Announces Presentation Of Data Supporting Pacritinib's Potential Benefit In Preventing Acute GVHD At The 62nd American Society Of Hematology Meeting
By PR Newswire
Dec 6, 2020 12:30 PM EST
PRESS RELEASES
CTI BioPharma Announces Publication Of Article Highlighting Pacritinib Data From The PAC203 Phase 2 Study In Myelofibrosis In Blood Advances
By PR Newswire
Nov 30, 2020 7:00 AM EST
PRESS RELEASES
CTI BioPharma Announces Oral Presentation At The 62nd American Society Of Hematology Meeting
By PR Newswire
Nov 4, 2020 11:41 AM EST
PRESS RELEASES
CTI BioPharma To Report Third Quarter 2020 Financial Results On November 10, 2020
By PR Newswire
Nov 2, 2020 4:05 PM EST
PRESS RELEASES
CTI BioPharma Initiates Rolling Submission Of New Drug Application (NDA) For Pacritinib In Myelofibrosis Patients With Severe Thrombocytopenia
By PR Newswire
Oct 13, 2020 7:00 AM EDT
PRESS RELEASES
CTI BioPharma To Submit A New Drug Application (NDA) For The Accelerated Approval Of Pacritinib For The Treatment Of Myelofibrosis Patients With Severe Thrombocytopenia
By PR Newswire
Sep 29, 2020 4:05 PM EDT
PRESS RELEASES
CTI BioPharma Announces Enrollment Of First Patient In COVID-19 PRE-VENT Phase 3 Clinical Trial
By PR Newswire
Jun 1, 2020 7:00 AM EDT
PRESS RELEASES
CTI Biopharma Announces Initiation Of Phase 3 PRE-VENT Study Evaluating Pacritinib In Hospitalized Patients With Severe COVID-19
By PR Newswire
Apr 27, 2020 7:00 AM EDT
PRESS RELEASES
CTI BioPharma Announces Closing Of Rights Offering
By PR Newswire
Mar 6, 2020 6:48 PM EST
PRESS RELEASES
CTI BioPharma Announces Commencement Of Rights Offering
By PR Newswire
Feb 14, 2020 7:00 AM EST
PRESS RELEASES
CTI BioPharma Announces Proposed Rights Offering
By PR Newswire
Feb 3, 2020 7:01 AM EST
PRESS RELEASES
CTI BioPharma Establishes Accelerated Approval Pathway For Pacritinib In Treating Myelofibrosis Patients With Severe Thrombocytopenia
By PR Newswire
Feb 3, 2020 7:00 AM EST
STOCKS
What Adam Feuerstein Got Right and Wrong About Biotech Stocks in 2016
By Adam Feuerstein
Dec 22, 2016 11:20 AM EST
STOCKS
2016 was a terrible year for biotech but the tweets were on point
By Adam Feuerstein
Dec 22, 2016 9:24 AM EST
STOCKS
Gilead Sciences' next challenge to Incyte's myelofibrosis drug dominance
By Adam Feuerstein
Nov 8, 2016 1:47 PM EST
MARKETS
Insider Trading Alert - LPNT, PATK And CTIC Traded By Insiders
By TheStreet Wire
May 31, 2016 10:30 AM EDT
MARKETS
Insider Trading Alert - SPTN, FL And CTIC Traded By Insiders
By TheStreet Wire
Mar 31, 2016 10:30 AM EDT
MARKETS
Insider Trading Alert - ATRS, CMT And CTIC Traded By Insiders
By TheStreet Wire
Mar 24, 2016 10:30 AM EDT
MARKETS
Insider Trading Alert - DRE And CTIC Traded By Insiders
By TheStreet Wire
Feb 29, 2016 10:45 AM EST
STOCKS
Despite Many Drug Blowups, CTI Bio CEO Bianco Turns S--t Into Gold for Himself
By Adam Feuerstein
Feb 15, 2016 2:40 PM EST
OPINION
3 big stocks you should stay away from right now
By Jonas Elmerraji
Feb 10, 2016 1:48 PM EST
OPINION
These under-$10 biotech stocks are about to trigger big breakout trades.
By Roberto Pedone
Jan 13, 2016 6:24 AM EST
MARKETS
Insider Trading Alert - BMTC, HA And CTIC Traded By Insiders
By TheStreet Wire
Nov 9, 2015 10:45 AM EST